NFKB1 and Blau syndrome: However, more recent in vitro studies using PBMCs or monocytes52–55 derived from patients with Blau syndrome showed reduced NF-κB activation and cytokines such as IL-1β in response to MDP, suggestive of a loss-of-function or “exhausted phenotype” in myeloid cells.